Addiction Medicine: Closing the Gap between Science and Practice

(lu) #1

Rosenthal, MD, Richard N., Head, Public Policy Section, American Academy of Addiction Psychiatry,
and Professor of Clinical Psychiatry and Chairman, Department of Psychiatry, St. Luke's Roosevelt
Hospital Center
Ross, MD, Stephen, Director, Substance Abuse Services, Bellevue Hospital Center and South Manhattan
Healthcare Network
Rotrosen, MD, John, Professor, Department of Psychiatry, New York University, School of Medicine
Samuels, JD, Paul N., Director and President, Legal Action Center
Savoy, LCSW, CASAC, Jeffrey R., Vice President and Director of Clinical Support Services, Odyssey
House, Inc.
Schwartz, MD, Bruce J., Director of Clinical Services for Substance Abuse, Montefiore Medical Center
Sederer, MD, Lloyd I., Medical Director, New York State, Office of Mental Health
Swanson, PhD, Arthur J., Program Director, University Behavioral Associates, Montefiore Medical
Center
Swern, Anne, District Attorney's Office, Kings County
Travis, JD, Jeremy, President, John Jay College of Criminal Justice
Wadalavage, Kevin, Vice President, Outreach Development Corporation
Weinstein, MPH, Naomi, Director, Phoenix House Center on Addiction and the Family (COAF)
Wilkens, PhD, Carrie, Clinical Director, Center for Motivation and Change


General Study Key Informants†


Albanese, MD, FACP, FASAM, Anthony, Chief of Hepatology and Chemical Dependency, VA Northern
California Healthcare System, Health Sciences Professor of Medicine & Psychiatry, UC Davis School
of Medicine
Allem, Johnny W., President and Chief Executive Officer, Johnson Institute
Amico, MDiv, Joseph M., President, National Association of Lesbian and Gay Addiction Professionals
Babor, PhD, MPH, Thomas F., Professor, Physicians Health Services Chair in Community Medicine and
Public Health, Department of Community Medicine and Health Care, University of Connecticut
Health Center
Bart, MD, FACP, FASAM, Gavin, Director, Division of Addiction Medicine, Department of Medicine,
Hennepin County Medical Center; Associate Professor of Medicine, University of Minnesota
Baxter, Sr., MD, FASM, Louis E., Executive Medical Director, Professional Assistance Program of New
Jersey
Beauchemin, Patricia, Executive Director, Therapeutic Communities of America‡
Berger, PhD, Thomas J., National Chair, PTSD & Substance Abuse Committee
Breyer, Ellen L., President and Chief Executive Officer, Hazelden Foundation
Brown, PhD, Stephanie, Director, The Addictions Institute
Callahan, DPA, James F., Executive Vice President, The American Board of Addiction Medicine, and
The ABAM Foundation
Carroll, PhD, Kathleen M., Professor of Psychiatry, Yale University, School of Medicine, Division of
Substance Abuse
Cimaglio, Barbara, Deputy Commissioner for Alcohol and Drug Abuse Programs, Vermont Department
of Health
Clark, MD, JD, MPH, H. Westley, Director, Center for Substance Abuse Treatment
Cohen, Michael, Executive Director, Florida Lawyers Assistance Program
Colston, MA, Stephenie W., Director, Substance Abuse Program, Florida Department of Children and
Families


† Titles and affiliations represent those at the time of Key Informant participation.
‡ Currently named Treatment Communities of America (TCA).

Free download pdf